Personalized medicine and pay-for-performance: should pharmaceutical firms be fully penalized when treatment fails?
-
1
Universidad de La Rioja
info
Zeitschrift:
PharmacoEconomics
ISSN: 1170-7690
Datum der Publikation: 2018
Art: Artikel
Andere Publikationen in: PharmacoEconomics
Institutionelles Repository:
lock_openOpen Access
Postprint